Home Biosimilar Antibodies Protein Tyrosine Kinase Others Patritumab deruxtecan For research use only.
Not for use in humans.

Patritumab deruxtecan

Synonyms: HER3-DXd

Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) composed of a fully human anti-HER3 IgG1 monoclonal antibody and a cytotixic topoisomerase I inhibitor. Patritumab deruxtecan shows anticancer activity.

Patritumab deruxtecan

CAS No. 2227102-46-5

Click to purchase products related to Patritumab deruxtecan

Purity & Quality Control

91.23

Biological Activity

Description Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) composed of a fully human anti-HER3 IgG1 monoclonal antibody and a cytotixic topoisomerase I inhibitor. Patritumab deruxtecan shows anticancer activity.

Product Details

CAS No. 2227102-46-5
ADC antiody Patritumab
ADC cytotoxin Dxd
Formulation 1xPBS
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Patritumab deruxtecan | Patritumab deruxtecan supplier | purchase Patritumab deruxtecan | Patritumab deruxtecan cost | Patritumab deruxtecan manufacturer | order Patritumab deruxtecan | Patritumab deruxtecan distributor